Left main coronary artery disease: pathophysiology, diagnosis, and treatment

Carlos Collet1, Davide Capodanno2,3, Yoshinobu Onuma4

  • 1Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

Insights

Unprotected left main coronary artery disease poses significant risks. While surgery is often preferred, new trials show catheter-based revascularization benefits selected patients, aiding treatment decisions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Unprotected left main coronary artery disease (ULMCAD) carries a high risk of mortality due to the large myocardial territory supplied.
  • Coronary angiography, while standard, has limitations in accurately assessing ULMCAD, potentially leading to misclassification.

Purpose of the Study:

  • To review the pathophysiology and diagnostic approaches for ULMCAD.
  • To discuss risk stratification models and revascularization strategies for ULMCAD.
  • To evaluate the role of new imaging techniques and recent clinical trial data.

Main Methods:

  • Review of existing literature on ULMCAD, including historical context and recent clinical trials.
  • Discussion of diagnostic modalities: coronary angiography, fractional flow reserve, and emerging imaging techniques.
  • Analysis of risk stratification tools and treatment outcomes for surgical vs. catheter-based revascularization.

Main Results:

  • Coronary angiography has interpretative challenges and limitations in ULMCAD assessment.
  • Surgical revascularization has historically improved survival in significant ULMCAD.
  • Recent trials indicate efficacy of percutaneous coronary intervention in select ULMCAD patients.

Conclusions:

  • Accurate diagnosis and risk stratification are crucial for managing ULMCAD.
  • Treatment decisions for ULMCAD require a Heart Team approach, considering both surgical and catheter-based options.
  • Advancements in imaging and interventional techniques are expanding treatment possibilities for ULMCAD.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
448